רקויפ מודוטאב 8 מ"ג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ROPINIROLE AS HYDROCHLORIDE 8 MG

Commercializzato da:

GLAXO SMITH KLINE (ISRAEL) LTD

Codice ATC:

N04BC04

Forma farmaceutica:

FILM COATED TABLETS - PROLONGED RELEASE

Via di somministrazione:

PER OS

Prodotto da:

SMITHKLINE BEECHAM PLC, UK

Gruppo terapeutico:

ROPINIROLE

Indicazioni terapeutiche:

Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. As adjunctive treatment to L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.

Data dell'autorizzazione:

2009-09-01